Literature DB >> 23722547

Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.

Carolina Pola1, Silvia C Formenti, Robert J Schneider.   

Abstract

The tumor microenvironment is a crucial player in the ability of cancer cells to acquire the ability to survive under the hypoxic environment and promote migration and invasion. Translational regulation is an essential part of cancer development and progression. Protein synthesis consumes considerable cellular metabolic energy and is therefore highly regulated, in turn controlling tumor cell proliferation and survival in extreme tumor-host conditions. Protein synthesis is typically downregulated by hypoxia, impairing cell proliferation and migration. Here, we show that breast cancer cells expressing integrin αvβ3, when engaging the extracellular matrix (ECM) protein vitronectin, strongly upregulate both mTOR activity and cap-dependent mRNA translation, which overrides their inhibition by hypoxia and facilitates tumor cell invasion. Interaction of vitronectin with integrin αvβ3 results in the continued activation of the kinase mTOR despite hypoxia through a mechanism that is dependent on integrin-linked kinase but is independent of focal adhesion kinase. Continuous activation of mTOR despite hypoxia involves release of translation initiation factor eIF4E from its repressor protein 4E-BP1, which is required for vitronectin-mediated tumor cell invasion. As integrin αvβ3 is associated with breast cancer cell invasion and metastasis to bone, we propose that the interaction with specific ECM proteins can influence cancer cell invasion, in part, by hyperactivation of mTOR, thereby promoting and sustaining protein synthesis under hypoxic conditions. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722547     DOI: 10.1158/0008-5472.CAN-13-0218

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.

Authors:  Wende Hao; Xuhui Zhang; Bingshui Xiu; Xiqin Yang; Shuofeng Hu; Zhiqiang Liu; Cuimi Duan; Shujuan Jin; Xiaomin Ying; Yanfeng Zhao; Xiaowei Han; Xiaopeng Hao; Yawen Fan; Heather Johnson; Di Meng; Jenny L Persson; Heqiu Zhang; XiaoYan Feng; Yan Huang
Journal:  Tumour Biol       Date:  2016-01-11

Review 2.  A review of the peripheral levels of regulation by thyroid hormone.

Authors:  Alexander G Little
Journal:  J Comp Physiol B       Date:  2016-04-09       Impact factor: 2.200

3.  Probing Cell Adhesion Profiles with a Microscale Adhesive Choice Assay.

Authors:  Harsha Kittur; Andy Tay; Avery Hua; Min Yu; Dino Di Carlo
Journal:  Biophys J       Date:  2017-10-17       Impact factor: 4.033

4.  Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells.

Authors:  Ru Zhou; Mingzu Zhang; Jinlin He; Jian Liu; Xingwei Sun; Peihong Ni
Journal:  ACS Omega       Date:  2022-06-07

5.  Vitronectin significantly influences prognosis in osteosarcoma.

Authors:  Kai Shi; Rui-Long Lan; Xuan Tao; Chao-Yang Wu; Hai-Feng Hong; Jian-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  New frontiers in translational control of the cancer genome.

Authors:  Morgan L Truitt; Davide Ruggero
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

7.  Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases.

Authors:  Gregory C Fox; Xinming Su; Jennifer L Davis; Yalin Xu; Kristin A Kwakwa; Michael H Ross; Francesca Fontana; Jingyu Xiang; Alison K Esser; Elizabeth Cordell; Kristen Pagliai; Ha X Dang; Jothilingam Sivapackiam; Sheila A Stewart; Christopher A Maher; Suzanne J Bakewell; James A J Fitzpatrick; Vijay Sharma; Samuel Achilefu; Deborah J Veis; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Mol Cancer Ther       Date:  2021-03-30       Impact factor: 6.261

8.  Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers.

Authors:  Taylan Turan; Meral Torun; Funda Atalay; Aymelek Gönenç
Journal:  Turk J Pharm Sci       Date:  2017-08-15

Review 9.  AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.

Authors:  Nico Hinz; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice.

Authors:  Jacopo Baglieri; Cuili Zhang; Shuang Liang; Xiao Liu; Takahiro Nishio; Sara B Rosenthal; Debanjan Dhar; Hua Su; Min Cong; Jidong Jia; Mojgan Hosseini; Michael Karin; Tatiana Kisseleva; David A Brenner
Journal:  Am J Pathol       Date:  2021-06-11       Impact factor: 5.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.